Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GMAB compared with BLTE: revenue, margins and what each company keeps, and the suppliers and customers both name
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
BLTE
Belite Bio, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
GMAB
Genmab A/S
vs
BLTE
Belite Bio, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GMAB
1
COAG
Hemab Therapeutics
customer
Shared
0
No shared counterparties.
Only BLTE
1
—
The Trustees of Columbia University in the City of New York
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
GMAB
Genmab A/S
Change
53.63
▲
+1.69%
· post 53.63
Mkt cap
$34.5B
BLTE
Belite Bio, Inc
Change
154.51
▲
+7.91%
· post 154.51
Closed
Nov 6 '26
Mkt cap
$6.1B
vs
Compare
Closed
Nov 6 '26
GMAB
Genmab A/S
vs
BLTE
Belite Bio, Inc
53.63
▲
+1.69%
post 53.63
Price
154.51
▲
+7.91%
post 154.51
$34.5B
Mkt cap
$6.1B
Change
Change
GMAB
53.63
▲
+1.69%
vs
BLTE
154.51
▲
+7.91%
Closed
Nov 6 '26